Source: International Congress 2014 – Nanomaterials and respiratory health



Rating:

Share or cite this content

Citations should be made in the following way:
P. Thorne (Iowa City, United States of America). In vitro and in vivo studies of nanoparticles and the lung. International Congress 2014 – Nanomaterials and respiratory health

Member's Comments

No comment yet.

Related content which might interest you: Non-viral and viral gene transfer in ex vivo and in vivo lung models Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Modeling in vitro, ex vivo or in vivo? Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 An in vivo comparison of two lung function systems Source: Eur Respir J 2005; 26: Suppl. 49, 177s Year: 2005 In vitro and in vivo laboratory models of pleural disease Source: Eur Respir Monogr 2020; 87: 29-47 Year: 2020 Potential therapeutic targets for lung repair during human ex vivo lung perfusion Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019 Year: 2020 In vivo and in vitro effects of variants of Parj2 in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 658s Year: 2005 Formation of tumor fragment spheroids (TFS) from lung cancer, in vitro model as like in vivo Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Comparison of drug delivery from spacers using a standard in vitro and an ex vivo method Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Impact of particle exposure systems on acute effects in an in vitro alveolar model Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections Year: 2021 Heparins inhibit lung cancer cells proliferation in vitro Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Characterisation of an ex vivo model of human airway epithelium Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Long-term translocation kinetics of ultrafine iridium particles to and across the rat lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 618s Year: 2006 A human-like ex vivo preclinical model for aerosol deposition studies Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Imaging of the interaction of fine particles and nanoparticles with lung cells Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see! Year: 2009